Table 2 Top associated variants (P < 5E−04) from the age-adjusted logistic regression with high-risk prostate cancer cases (ISUP grade group 3-5; HRPCa; N = 203) against low-risk or no PCa (LR/No PCa; N = 461)

From: Prostate cancer genetic risk and associated aggressive disease in men of African ancestry

CHR

SNP

BP

A1/A2 alleles

OR (95% CI)

P-value

MAF HRPCa

MAF LR/No PCa

MAF African ancestry

Overlapped/Closest genes (distance away)

SIFT

PolyPhen

ClinVar

3

rs78726268

183037313

T/C

4.78 (2.39–9.57)

9.74E–06

0.062

0.014

0.026

MCCC1

T

B

B/LB

10

rs11009235

33132620

A/G

1.73 (1.34–2.22)

2.23E–05

0.436

0.321

0.412

IATPR (15.8 kb), NRP1 (44.9 kb)

   

6

rs34644326

63712963

C/G

3.15 (1.82–5.44)

4.02E–05

0.079

0.029

0.048

PHF3

T

 

B

X

rs2897495

10808235

A/G

2.04 (1.45–2.86)

4.37E–05

0.463

0.3

0.437

MID1

   

11

rs1194099

65582378

A/T

1.82 (1.36–2.43)

5.23E–05

0.264

0.168

0.158

EHBP1L1

Ta

  

14

rs28670114

93622023

C/T

1.91 (1.39–2.61)

5.87E–05

0.224

0.137

0.164

UNC79

Ta

B

 

11

rs75062275

65581112

A/G

1.79 (1.34–2.39)

7.75E−05

0.261

0.168

0.154

EHBP1L1

Ta

  

12

rs11068997

109945336

A/G

2.05 (1.44–2.94)

8.25E−05

0.16

0.089

0.094

TCHP, GIT2

Da

 

B

5

rs12658464

122153427

T/C

0.61 (0.47–0.78)

1.06E−04

0.291

0.403

0.543

ZNF474

   

16

rs61734425

81207531

G/T

2.55 (1.59–4.11)

1.13E−04

0.096

0.045

0.036

PKD1L2

   

5

rs10074434

135153492

G/T

0.62 (0.49–0.79)

1.39E−04

0.35

0.457

0.548

PITX1-AS1

   

16

rs75279347

88532007

A/G

2.37 (1.5–3.74)

2.24E−04

0.099

0.044

0.038

ZFPM1

T

  

6

rs11970638

27867099

C/T

1.91 (1.35–2.71)

2.72E−04

0.158

0.09

0.088

H1-5

T

  

16

rs1135045

23478390

C/G

0.64 (0.5–0.81)

3.04E−04

0.399

0.505

0.416

GGA2

T

B

 

15

rs80278342

101313285

A/G

3.1 (1.68–5.74)

3.07E−04

0.062

0.021

0.012

PCSK6

   

10

rs8473

128101314

T/C

0.64 (0.5–0.82)

3.09E−04

0.416

0.521

0.534

MKI67

T

  

2

rs60322991

219216123

T/C

0.57 (0.42–0.78)

3.42E−04

0.153

0.241

0.153

ABCB6

D

PD

B

12

rs7963300

53864157

A/G

2 (1.37–2 .92)

3.43E−04

0.144

0.082

0.092

ENSG00000286069

   

7

rs877834

25228315

C/T

1.71 (1.28–2.3)

3.54E−04

0.239

0.154

0.117

NPVF

D

PD

 

10

rs35299879

122841282

A/C

2.63 (1.54–4.49)

3.75E−04

0.074

0.028

0.014

CUZD1

T

B

 

10

rs34246902

122841318

C/G

2.63 (1.54–4.49)

3.75E−04

0.074

0.028

0.014

CUZD1

T

B

 

9

rs2075662

98985952

A/G

0.59 (0.44–0.79)

3.78E−04

0.182

0.274

0.312

COL15A1

D

P

 

3

rs7648947

43132737

A/G

0.62 (0.47–0.81)

3.98E−04

0.251

0.347

0.361

POMGNT2 (26.7 kb)

   

17

rs77944357

69215844

T/G

2.83 (1.59–5.03)

4.01E−04

0.067

0.023

0.018

ABCA10

D

PrD

 

16

rs9937453

22144308

A/G

1.55 (1.21–1.99)

4.80E−04

0.51

0.413

0.53

VWA3A

T

B

 
  1. African ancestry minor allele frequency (of allele A1) was retrieved from gnomAD v3.1.2.
  2. CHR chromosome, SNP single nucleotide polymorphism, BP base pair (GRCh38), A1 minor allele, A2 major allele, OR odds ratio, CI confidence interval, MAF minor allele frequency, T tolerated, B benign, LB likely benign, D deleterious, PD possibly damaging, PrD probably damaging.
  3. aLow confidence.